Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine‐refractory thyroid cancer
暂无分享,去创建一个
S. Baxi | A. Ho | D. Pfister | J. Fagin | R. Ghossein | E. Sherman | M. Fury | C. Sima | L. Dunn | S. Haque | G. Cullen